CMV DNA BY PCR

CMV DNA by PCR is a molecular diagnostic test that detects and quantifies cytomegalovirus (CMV) genetic material in clinical specimens using real-time polymerase chain reaction. It provides highly sensitive and specific detection of active CMV infection by reporting qualitative results (detected/not detected) and, when required, a quantitative viral load in copies/mL. With home sample collection available across Dubai, this test enables timely diagnosis and monitoring for pregnant women, newborns, and immunocompromised patients while minimising travel and exposure.

• CMV DNA — Qualitative (Detected / Not detected)
• CMV Viral Load — Quantitative (copies/mL)
• Specimen Type — Plasma / Whole blood / Urine / Saliva
• PCR assay genomic target (viral gene marker)

• Suspected congenital CMV in newborns or infants
• Pregnant women with exposure or suspected primary CMV infection
• Monitoring CMV reactivation in transplant recipients
• Immunocompromised patients with unexplained fever or organ dysfunction
• Assessing response to antiviral therapy or surveillance in high‑risk individuals

• High sensitivity and specificity for early detection of active CMV infection
• Quantitative viral load for treatment monitoring and clinical decision-making
• Convenient home sample collection across Dubai with accredited laboratory processing
• Rapid turnaround to support timely clinical management
• Useful for pregnancy care, neonatal screening, and transplant patient surveillance

• At‑home blood sample collection (EDTA plasma or whole blood) or neonatal urine/saliva when indicated
• No fasting required prior to sample collection
• Provide clinical indication (pregnancy, transplant status, symptoms) or physician requisition if available
• Valid Emirates ID and contact details for reporting; phlebotomist handles specimen transport and cold‑chain as needed